natgillin/translations-raw huggingface dataset:
These data are then fed by national drug monitoring centres (Reitox network) to the Lisbon agency for analysis, resulting in a variety of information products conveying the broader European picture.
Te podatke nato nacionalni centri za spremljanje drog (mreža Reitox) posredujejo Centru v Lizbono, da jih analizira in sestavi različno informacijsko gradivo, v katerem je predstavljena širša evropska slika.
While the EMCDDA is primarily European in focus, it also works with partners in other world regions, exchanging information and expertise.
Čeprav se EMCDDA osredotoča predvsem na Evropo, sodeluje tudi s partnerji iz drugih svetovnih regij ter si z njimi izmenjuje podatke in strokovno znanje.
Collaboration with European and international organisations in the drugs field is also central to its work as a means of enhancing understanding of the global drugs phenomenon.
Tudi sodelovanje z evropskimi in mednarodnimi organizacijami na področju drog je zelo pomembno pri njegovem delu in se uporablja za boljše razumevanje problematike drog v svetu.
The EMCDDA works on the principle that sound information is the key to an effective strategy on drugs.
EMCDDA deluje po načelu, da so zanesljive informacije ključ do učinkovite strategije na področju drog.
Although it does not propose policy, the agency is now making a clear impact on decision-making through its analyses, standards and tools.
Čeprav Center ne predlaga politike, jasno vpliva na odločanje, in sicer z analizami, standardi in orodji, ki jih zagotavlja.
EMCDDA, your reference point on drugs in Europe
EMCDDA, vaša referenčna točka za droge v Evropi
The state of the drugs problem in Europe
Stanje na področju problematike drog v Evropi
Reitox network
Mreža Reitox
The EMCDDA’s main output is its yearly overview of the European drug phenomenon which it presents in a multilingual annual report package.
Glavni izdelek centra EMCDDA je njegov letni pregled problematike drog v Evropi, ki ga predstavi v večjezičnem svežnju letnih poročil.
This is essential reading for policymakers, scientists and practitioners in the drugs field or anyone seeking the latest findings on drugs in Europe.
Za oblikovalce politike, znanstvenike in vse, ki delujejo na terenu ali iščejo najnovejše ugotovitve o drogah v Evropi, je to obvezno branje.
Annual report: the state of the drugs problem in Europe, an overview of the drug phenomenon in some 30 European countries — www.emcdda.europa.eu/publications/annual-report Statistical bulletin, over 500 tables and graphs on the European drug situation www.emcdda.europa.eu/stats/home Selected issues, annual reviews on issues of topical interest www.emcdda.europa.eu/publications/selected-issues Country overviews, over 30 national drug situations at a glance www.emcdda.europa.eu/publications/country-overviews Reitox national reports, overviews of national drug situations www.emcdda.europa.eu/publications/national-reports
Letno poročilo: Stanje na področju problematike drog v Evropi, pregled stanja na področju drog v približno 30 evropskih državah: www.emcdda.europa.eu/publications/annual-report
Monitoring the drug situation
Spremljanje stanja na področju drog
The EMCDDA would not be complete without Reitox — the European information network on drugs and drug addiction — which comprises national drug monitoring centres or ‘focal points’ in the 27 EU Member States, candidate countries to the EU, Norway and at the European Commission.
EMCDDA ne bi bil popoln brez mreže Reitox, evropske informacijske mreže za droge in zasvojenost z drogami. Mrežo sestavljajo nacionalni centri za spremljanje drog ali „kontaktne informacijske točke“ v 27 državah članicah EU, državah kandidatkah za pristop k EU, na Norveškem in pri Evropski komisiji.
These bodies are the main information interface between the EMCDDA and its Member States.
Ti organi so glavni informacijski vmesnik med centrom EMCDDA in njegovimi državami članicami.
As such, they provide national drug information to the agency for EU-level analysis and play the role of EMCDDA ‘ambassadors’ at home.
Kot taki Centru zagotavljajo nacionalne podatke o drogah za analizo na ravni EU in so „ambasadorji“ centra EMCDDA v domačih državah.
Understanding the nature and scale of the drugs problem is a critical requirement for effective policymaking and action.
Razumevanje narave in razsežnosti problematike drog je nujno potrebno za učinkovito oblikovanje politike in ukrepanje.
The EMCDDA uses a variety of monitoring methods and tools (e.g. key indicators, core datasets) which offer countries a ‘common language’ with which to interpret the drug phenomenon.
Poleg spremljanja aktualnega stanja na področju drog EMCDDA ostaja zelo pozoren na pojav novih drog in trende, ki bi lahko v prihodnosti predstavljali grožnjo naši družbi.
As well as monitoring the drug situation today, the EMCDDA is ever vigilant to new drugs and trends that may pose a future threat to our societies.
Na tem področju je dejaven pri zgodnjem opozarjanju in ocenjevanju tveganja s pravnimi instrumenti in študijami primerov.
Here it plays an active role in early-warning and risk-assessment activities through legal instruments and case studies.
Spremljanje razmer na področju drog: www.emcdda.europa.eu/drug-situation
Monitoring drug interventions, laws and policies is firmly enshrined in the EMCDDA’s work.
V delu centra EMCDDA je močno zasidrano spremljanje ukrepov, zakonov in politik na področju drog.
By providing a European overview of such responses to drug problems, it helps countries follow trends and design appropriate strategies.
Z zagotavljanjem evropskega pregleda takih odzivov na problematiko drog državam pomaga, da spremljajo trende in oblikujejo ustrezne strategije.
The agency has developed a number of mechanisms to describe the availability and nature of responses as well as a variety of tools to evaluate them.
Center je razvil številne mehanizme za opisovanje dosegljivosti in narave odzivov ter različna orodja za njihovo vrednotenje.
Its Best practice portal helps those working in the areas of prevention, treatment, harm reduction and social reintegration take evidence-based decisions when planning interventions.
Best practice portal, portal na katerem so zbrani primeri najboljše prakse in ponujena orodja za izboljšanje kakovosti ukrepov: www.emcdda.europa.eu/responses/best-practice
Best practice portal, a gateway highlighting examples of best practice and offering tools to improve the quality of interventions — www.emcdda.europa.eu/responses/best-practice Drug treatment overviews, an online resource mapping the availability of drug-related treatment in Europe — www.emcdda.europa.eu/responses/treatment-overviews European Legal Database on Drugs (ELDD), an entry-point to information on drug-related legislation in Europe — eldd.emcdda.europa.eu National drug strategies and action plans, a repository of these key national documents www.emcdda.europa.eu/policy-and-law/national/strategies EU drug policy activities, an online database of policy documents published by the EU institutions in the field of drugs — www.emcdda.europa.eu/policy-and-law/eu-activities
Dejavnosti politike EU na področju drog, spletna podatkovna zbirka pravnih in političnih dokumentov s področja drog, ki jih objavljajo institucije EU: www.emcdda.europa.eu/policy-and-law/eu-activities
European Monitoring Centrefor Drugs and Drug Addiction
Evropski center za spremljanje drog in zasvojenosti z drogami
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the central reference pointfor drug information in the European Union.
Evropski center za spremljanje drog in zasvojenosti z drogami (EMCDDA) je osrednja referenčna točkaza pridobivanje informacij o drogah v Evropski Uniji (EU).
Set up in 1993, and based in Lisbon, its role is to provide the EU and its Member States with objective, reliable and comparable information on drugs and drugaddiction.
Naloga EMCDDA, ustanovljenega leta 1993s sedežem v Lizboni, je EU in državam članicam zagotavljati objektivne, zanesljive in primerljiveinformacije na področju drog in zasvojenosti. Je ena od decentraliziranih agencij EU.
Evidence-based information on drugs is one of the most vital tools at our disposal today to address thisglobal challenge.
Eno najpomembnejših orodij, ki jih imamo na voljo za reševanje tega globalnega izziva, so na dokazihtemelječe informacije.
By offering information of this kind within the EU, the EMCDDA helps policy-makers,researchers and specialists in the field understand the nature of the problem and formulate appropriateresponses.
Z zagotavljanjem tovrstnih informacij znotraj EU EMCDDA pomaga oblikovalcempolitike, raziskovalcem in strokovnjakom s področja drog razumeti naravo problema in oblikovatiprimerne ukrepe.
At the heart of the Centre’s work are efforts to improve the comparability of drug information across Europe and to devise the methods and tools required to achieve this.
Osnovni nalogi EMCDDA sta prizadevanje za izboljšanje primerljivosti podatkov o drogah v Evropi terizoblikovanje metod in instrumentov, potrebnih za dosego tega cilja.
As a result of efforts to date,countries can now view how they fit into the wider European picture and examine common problemsandgoals.
Na osnovi do zdaj zbranihpodatkov lahko posamezne države preverijo, v kolikšni meri so na področju drog primerljive z drugimievropskimi državami in v kolikšni meri imajo skupne cilje in probleme.
A key feature of the drug phenomenon is its shifting, dynamic nature, and tracking new developments is acentral task of the EMCDDA.
Ključna značilnost pojava drog je njegova spremenljiva dinamična narava, zato je sledenje novimsmerem razvoja ena osrednjih nalog EMCDDA.
During its first 10 years (1993–2003), the Centre recorded changes both inthe nature of the drug problem and in countries’ responses and policies.
V prvih 10 letih obstoja (1993–2003) je EMCDDAbeležil spremembe tako v naravi problema drog kot tudi v odzivih držav in njihovih politikah.
While the agency identified keydifferences in this period, it also witnessed the emergence of common patterns and trends.
Hkrati s ključnimi spremembami v tem obdobju se je EMCDDA soočil tudi s pojavom skupnih vzorcev intrendov.
Providing an accurate and up-to-date picture of this ever-changing landscape forms the cornerstone of theagency’s activities under its 2004–06 work programme.
Zagotavljanje točne in posodobljene slike tega nenehno spreminjajočega se področja je temeljnadejavnost EMCDDA, ki je opredeljena v programu dela za obdobje 2004–2006.
Although a great deal has already been achieved,much remains to be done to perfect monitoring instruments and develop a truly ‘common language’ withwhich to describe this European and global phenomenon.
Čeprav je EMCDDAže precej dosegel, pa bo treba še veliko narediti za izpopolnitev nadzornih instrumentov in razvoj»skupnega jezika«, s katerim bi opisali ta evropski in globalni pojav.
Statutory bodies
Organi in telesa EMCDDA
Core tasks
Ključne naloge
The EMCDDA’s mission statement sets out theagency’s four main tasks:
Ustanovitev in poslanstvo EMCDDA opredeljujejoštiri ključne naloge:
•collecting and analysing existing data;
•zbiranje in analiziranje obstoječih podatkov,•izboljševanje metod primerjanja podatkov,•razširjanje podatkov in informacij in
AbouttheEMCDDA
PredstavitevEMCDDA
•improving data-comparison methods;
•sodelovanje z institucijami EU, mednarodnimipartnerji in državami nečlanicami EU.
The EMCDDA’s main decision-making body is its Management Board which is composed of: one representative of each EU Member State; two representatives of the European Commission;twopersons highly qualified in the field of drugs designated by the European Parliament and a number of observer members, including Norway and international organisations.
Glavni organ EMCDDA, ki oblikuje in sprejemaodločitve, je Upravni odbor, ki ga sestavljajopredstavnik vsake države članice EU, dvapredstavnika Evropske komisije, dve visokousposobljeni osebi s področja drog, ki ju imenuje Evropski parlament, in številniopazovalci, vključno iz Norveške in mednarodnihorganizacij.
The information collected, analysed and disseminatedby the EMCDDA focuses on:
Informacije, ki jih EMCDDA zbira, analizira inrazširja, se nanašajo predvsem na:
•the demand and reduction of the demandfordrugs;
•povpraševanje in zmanjševanjepovpraševanja po drogah,
This assembly of national representatives guarantees that the interests of all European citizensare fully represented in EMCDDA decision-making.
Ta skupina državnih predstavnikov jamči,da so pri odločanju v EMCDDA polno zastopani interesi državljanov EU.
Its Chair and Vice-Chair are elected for a three-year mandate.
Predsednik inpodpredsednik Upravnega odbora sta izvoljena zatri leta.
•national and EU strategies and policies;
•nacionalne strategije in strategije EU ternjihove politike,
•international cooperation and the geopoliticsofsupply;
•mednarodno sodelovanje in geopolitikoponudbe,
•control of the trade in narcotic drugs,psychotropic substances and precursors; and
Znanstveno neoporečnost EMCDDA ščiti Znanstveniodbor, ki nudi nasvete in pomoč pri vseh strokovnihvprašanjih, ki mu jih zastavita direktor ali Upravniodbor.
Its Chair and Vice-Chair are elected for a three-year mandate.
•nadzor nad trgovanjem z drogami,psihotropnimi snovmi in predhodnimisestavinami in
•implications of the drugs phenomenon forproducer, consumer and transit countries.
•posledice, ki jih ima pojav drog na državeproizvajalke, države potrošnice in tranzitnedržave.
Working teams
Delovne skupine
2004–06 work programme
Program dela za obdobje 2004–2006
The EMCDDA’s work is structured around four coreprogramme teams which focus on:
Delo EMCDDA je organizirano v okviru štirihosrednjih programskih skupin, ki se ukvarjajo s:
•monitoring and analysing the drug situation;
•spremljanjem in analizo stanja na področjudrog,
The EMCDDA’s 2004–06 work programme is setagainst a backdrop of political innovation andchange, characterised by EU enlargement and a new EU strategy and action plan on drugs.
Delovni program EMCDDA za obdobje2004–2006 je bil izoblikovan v času političnihinovacij in sprememb, do katerih prihaja s širitvijo EU in ki jih zaznamujeta nova strategija ter novakcijski načrt EU na področju drog.
•monitoring and analysing responses to the drugsituation;
•spremljanjem in analizo ukrepov na področjudrog,
Key activities under the three-year programme are:
Ključne aktivnosti triletnega programa so:
•monitoring and assessing new synthetic drugs;and
•spremljanjem in ocenjevanjem novih sintetičnih drog in
•monitoring and analysing data and improvingdata quality;
•spremljanje in analiza podatkov terizboljševanje njihove kakovosti,
•detecting and synthesising new developments;and
•odkrivanje in sinteza novih razvojnih smeri in
•monitoring and analysing national and EUstrategies and policies and their impact on thedrug situation.
•spremljanjem in analizo nacionalnih strategijin strategij EU ter njihovih politik in učinkov nastanje na področju drog.
•undertaking scientific and thematic analyses inline with emerging trends and policy interests.
•izvajanje znanstvenih in tematskih analiz v skladu s pojavljajočimi se trendi in interesipolitike.
Activities in these areas are supported, or promoted,by the following auxiliary programmes:
Dejavnosti na teh področjih podpirajo alipospešujejo naslednji pomožni programi:
•Reitox coordination;
•koordinacija Reitox (Evropske informacijskemreže za droge in zasvojenost z drogami),
•information technology; and
•obveščanje in razširjanje informacij,•informacijska tehnologija in•podporne storitve.
The full text of the work programme is available at http://www.emcdda.eu.int
Celotno besedilo delovnega programa je na voljona spletnem naslovu: http://www.emcdda.eu.int
Drug situation
Stanje na področju drog
Understanding the scale and nature of the drug problem is a critical requirement foreffectivepolicy-making and action.
Razumevanje obsega in vrste problemov na področju drog je bistveno za učinkovito oblikovanje politike in ukrepov.
Monitoring and analysing the EU drug situation are therefore primaryactivities of the EMCDDA.
Spremljanje in analiza stanja na področju drog v EU sta zato prvenstveni dejavnosti EMCDDA.
Collecting reliable, comparable and up-to-date information on drug use and its consequences is both methodologicallyand practically challenging.
Zbiranje zanesljivih, primerljivih in najnovejših informacij o uporabi drog in posledicah uporabe je zahtevno takometodološko kot praktično.
The EMCDDA therefore works in partnership with national experts to develop theinfrastructure and technical tools necessary for countries to gather data in a uniform way.
EMCDDA v sodelovanju s strokovnjaki na nacionalni ravni razvija infrastrukturo intehnične pripomočke, ki jih države nujno potrebujejo za zbiranje podatkov na enoten način.
Such instruments offercountries a ‘common language’ with which to interpret and compare the nature of their shared problem.
Takšni instrumentinudijo državam »skupen jezik«, ki jim omogoča tolmačenje in primerjavo skupne problematike.
They alsohelp policy-makers across the EU identify key issues, take action and assess the impact of their work.
Poleg tegaoblikovalcem politike znotraj EU pomaga pri ugotavljanju poglavitnih problemov, sprejemanju ukrepov in priocenjevanju učinkov njihovega dela.
Priorities under the 2004–06 work programme include: improving data quality via key indicators; consolidatingdata-collection strategies; and fully exploiting the analytical potential of information gathered by the EMCDDAand its partners.
Med prednostne naloge delovnega programa za obdobje 2004–2006 spadajo: izboljševanje kakovostipodatkov s pomočjo ključnih kazalcev, utrjevanje strategij zbiranja podatkov in izkoriščanje analitičnegapotenciala informacij, ki jih zbira EMCDDA skupaj s svojimi partnerji.
Key indicators
Ključni kazalci
At the heart of the EMCDDA’s information system are five key harmonised epidemiological indicators: standardtools for collecting and reporting comparable drug data.
Jedro informacijskega sistema EMCDDA je pet usklajenih epidemioloških kazalcev: standardnih orodij zazbiranje in sporočanje primerljivih podatkov o drogah.
•prevalence and patterns of drug use among the general population;
Ti vključujejo: •razširjenost in vzorce uporabe drog v splošni populaciji,•razširjenost in vzorce problematične uporabe drog, •nalezljive bolezni, povezane z uporabo drog, •smrti, povezane z uporabo drog, in umrljivost uživalcev drog in•povpraševanje po zdravljenju zaradi težav z drogami.
Through these indicators, the agency is gaining an increased understanding of Europe’s drug problem and isgenerating the sound evidence needed for effective decision-making.
S temi ključnimi kazalci Center izboljšuje in širi razumevanje problema drog v Evropi ter oblikuje zanesljivopodlago, ki je potrebna za učinkovito odločanje.
Expanding the knowledge base
Širitev podatkovne zbirke
Analysis, assessment and forecasting
Analiza, ocene in napovedi
The EMCDDA is expanding its knowledge basebydeveloping data-collection strategies in newareasof policy concern.
Center širi svojo podatkovno zbirko z razvojemstrategij zbiranja podatkov na novih področjih, ki jihobravnava oziroma zajema politika na področjudrog.
In some of these areas,dataavailability is already substantial, whileinothers it varies according to the stage ofprojectdevelopment.
Na nekaterih od teh področij je na voljo žezelo veliko podatkov, na drugih pa njihova količinaniha in je odvisna od razvojne faze projekta.
Providing an evidence base for timely,methodologically sound and policy-relevant analysesof the drug situation is a core motivation forcollecting data. To ensure that maximum value isdrawn from its data findings, the EMCDDA carriesout in-depth analyses to provide new insight intokeypolicy areas.
Med glavne razloge za zbiranje podatkov spadazagotavljanje podatkovne baze za časovnoustrezne, metodološko zanesljive in za politikopomembne analize razmer na področju drog.EMCDDA izvaja poglobljene analize, ki dajejo novvpogled v ključna področja politike, in s temzagotavlja, da so njegove ugotovitve in podatkimaksimalno izkoriščeni.
Areas covered include:
Analize vključujejo:
•drug markets and availability;
•pojavljajoče se nove trende pri uživanju drog,njihove učinke in posledice,
•emerging new trends in drug consumption,theirimpact and consequences;
Zajeta so naslednja področja: •kriminal, povezan z drogami,•trg drog in njihova razpoložljivost, •mladostniki in ranljivost,•socialna izključenost zaradi drog in •vzorci uporabe in novi trendi glede drog.
•youth and vulnerability;
•obseg uporabe drog in stopnjo s tempovezanih problemov,
•drug-related social exclusion; and
•razmerje med vzorci uporabe drog innjihovimi posledicami,
•the relationship between patterns of use andtheir consequences;
Da bi dopolnili zbirko in podatke postavili v širšikontekst, Center pregleduje tudi poročila oznanstvenih raziskavah.
•risk/protective factors, individual and socialfactors, market and economic issues; and
•dejavnike tveganja in zaščite, individualne insocialne dejavnike, tržne in gospodarskevidike in
•epidemiological methods for improvedunderstanding of the effects of interventions,and other factors, on the drug situation.
•epidemiološke metode za boljše razumevanjeučinkov intervencij in drugih dejavnikov stanja na področju drog.
Responses
Ukrepi
Knowing which interventions are effective in dealing with a specific drug situation iscrucial forpolicy-makers to design successful response strategies.
Informacija o tem, kateri posegi bodo v posameznih situacijah v zvezi z drogami učinkoviti, je za oblikovanje uspešnih strategij ključnega pomena.
Monitoring and analysing responses tothe drug problem are therefore central tasks of the EMCDDA.
Spremljanje in analiza ukrepov na področjuproblematike drog sta zato bistveni nalogi EMCDDA.
One of the agency’s main challenges is providing access to timely, evidence-based information on responseoptions in the health, educational, social and criminal justice spheres.
Eden poglavitnih izzivov Centra je omogočiti dostop do periodično ustreznih in na dokazih temelječih podatkovo možnih ukrepih na zdravstvenem, izobraževalnem, socialnem in kazenskopravnem področju.
The Centre also helps exploit research andpromote scientific knowledge on responses as the basis for decision-making in policy and practice.
Center pomagatudi, da raziskave in znanstvena spoznanja služijo kot osnova pri odločanju v politiki in praksi.
Priorities under the 2004–06 work programme include: analysing trends and new developments in the field ofresponses; developing further structured information-processing techniques; and providing examples both of bestpractice and quality-management tools.
Med prednostne naloge delovnega programa za obdobje 2004–2006 spadajo: analiza trendov in novihrazvojnih smernic na področju ukrepov, razvoj bolj strukturiranih tehnik za obdelavo informacij in ponujanjeprimerov dobre prakse kot tudi primerov orodij za obvladovanje kakovosti.
The EMCDDA monitors and analyses the availability, accessibility and quality of responses in the fields of drugprevention, treatment, social rehabilitation and harm reduction. It also covers responses available to drug users in the criminal justice system.
EMCDDA spremlja in analizira razpoložljivost, dostopnost in kakovost ukrepov na področjih preprečevanja,zdravljenja, socialne rehabilitacije in zmanjševanja škodljivih posledic zaradi drog.
•prevent the transition from experimental to problem use;
Med njegove dejavnostispada tudi pokrivanje vprašanj, ki se porajajo uživalcem drog v kazenskopravnih zadevah.
Information tools and instruments
Pridobivanje informacij
Promoting best practice and evaluation in responsesto the drug problem receives special attention in EMCDDA work programmes.
Delovni programi Centra posvečajo posebnopozornost podpori dobrih praks in ukrepom gledeproblematike drog.
The EMCDDA analyses and interprets a wide rangeof response options in the field of drugs in order toguide policy-makers and professionals in how to dealwith the problem more effectively.
Center analizira in pojasnjuje širok obseg možnihukrepov na področju drog, z namenom usmerjatioblikovalce politike in strokovnjake pri vprašanju,kako se učinkoviteje soočiti s problemom.